Second-Line Antiretroviral Treatment Outcome in HIV-Infected Patients Coinfected with Tuberculosis in Pakistan.
Muhammad ShafiqSana ZafarAftab AhmadAbeer KazmiAlina FatimaTanvir Ahmed MujahidRizwan QaziNasim AkhterAmir ShahzadSaif Ur RehmanMuhammad Adnan ShereenMuhammad Zeeshan HyderPublished in: BioMed research international (2023)
In HIV-/TB-coinfected patients, CD4 count, CD4 gain, and VF remained comparable to HIV patients with no TB infection. ATT significantly affects the treatment outcome, suggesting drug-to-drug interactions. These factors are important to revisit the therapeutic guidelines to maximize the benefit of dual therapy in resource-limited settings.
Keyphrases
- antiretroviral therapy
- hiv infected patients
- hiv infected
- hiv aids
- hiv positive
- human immunodeficiency virus
- mycobacterium tuberculosis
- hiv testing
- hepatitis c virus
- end stage renal disease
- ejection fraction
- men who have sex with men
- newly diagnosed
- south africa
- stem cells
- chronic kidney disease
- peritoneal dialysis
- peripheral blood
- tertiary care
- electronic health record